087010 - Peptron, Inc.

087010 Summary
Biopharma
Stock Price & Overview
₩157,300 +10,700 (+7.30%) Close · Sep 4, 2026 KST
KOSDAQ | ₩KRW | Close: ₩157,300  ≈ US$112  ·  Market cap ₩3.7tn (≈ $2.6bn)

Material matter affecting investment judgment (clinical trial plan applied for)

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.
Korean form name: 투자판단관련주요경영사항(임상시험계획승인신청) (PT403의 제1상 임상시험계획 승인 신청)